This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Macopharma, Université Du Droit Et De La Santé De Lille 2. Active years: 2014.
Company Filing History:
1 out of 26 
1 out of 29 
1 out of 2 Years Active: 2014
Title: Bruno Lukowiak: Innovator in Insulin-Secreting Cell Preservation
Introduction
Bruno Lukowiak is a notable inventor based in Aubigny en Artois, France. He has made significant contributions to the field of medical technology, particularly in the preservation of insulin-secreting cells for transplantation. His innovative approach aims to improve the outcomes for patients requiring such transplants.
Latest Patents
Lukowiak holds a patent for a process designed to preserve insulin-secreting cells intended for transplantation. The patent, titled "Process for preserving insulin-secreting cells intended to be transplanted," outlines a method that includes several key steps. These steps involve introducing an initial volume of culture medium and insulin-secreting cells into a culture container, providing a source of culture medium, and regularly replacing the culture medium in the container at intervals of less than 8 hours. This process ensures the renewal of the culture medium, which is crucial for maintaining the viability of the cells.
Career Highlights
Throughout his career, Bruno Lukowiak has worked with reputable organizations, including Macopharma and the Centre Hospitalier Régional Universitaire De Lille. His experience in these institutions has allowed him to develop and refine his innovative techniques in cell preservation.
Collaborations
Lukowiak has collaborated with various professionals in his field, including Julie Kerr-Conte. Their joint efforts have contributed to advancements in the preservation of insulin-secreting cells, enhancing the potential for successful transplants.
Conclusion
Bruno Lukowiak's work in the preservation of insulin-secreting cells represents a significant advancement in medical technology. His innovative patent and collaborations highlight his commitment to improving patient outcomes in transplantation.